- The Evolving Landscape of Pancreatic Cancer.
- Krishnan M.
- JCO Oncol Pract. 2022 Nov 10:OP2200636. doi: 10.1200/OP.22.00636. Epub ahead of print.
- PMID: 36354334
- PubMed abstract
- Source abstract
- Commentary
- Free Full Text
- Study Suggests a PARP Inhibitors Has Wider Cancer Applications.
- [No author given]
- Inside Precision Medicine. Topics. Oncology. 2022 Nov 9.
- Research news
- Free Full Text
•• Original research:
A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination genes.
- PMID: 36253484
- PubMed abstract
- Free Full Text
- Genomic and transcriptomic profiling indicates the prognosis significance of mutational signature for TMB-high subtype in Chinese patients with gastric cancer.
- Cheng Y, Bu D, Zhang Q, Sun R, Lyle S, Zhao G, Dong L, Li H, Zhao Y, Yu J, Hao X.
- J Adv Res. 2022 Nov 6:S2090-1232(22)00248-X. doi: 10.1016/j.jare.2022.10.019. Epub ahead of print.
- PMID: 36351537
- PubMed abstract